子宫内膜异位症中子宫内膜DNA损伤应答的调控异常
这项病例对照研究比较了40例子宫内膜异位症女性和26例对照女性在位内膜的DNA损伤应答(DDR),发现DDR基因表达和γ-H2AFX免疫定位强度在病例组显著升高(P<0.05),且GADD家族蛋白丰度存在差异;DNA修复基因转录本在增殖中期多数上调而在分泌中期多数下调。
要点
- 子宫内膜异位症患者在位内膜DDR基因表达和γ-H2AFX强度显著高于对照(P<0.05)。
- GADD家族蛋白在病例组在位内膜中丰度存在差异,两期均可见。
- DNA修复基因转录本在增殖中期多数上调,分泌中期多数下调。
核心结论
- 子宫内膜异位症患者在位内膜的DDR基因表达和DNA损伤标志物γ-H2AFX强度显著高于无疾病对照(P<0.05)。
研究设计与样本
- 病例对照研究,2015–2019年纳入40例子宫内膜异位症女性(年龄31.9±0.81岁)和26例对照女性(年龄31.4±1.02岁)。
- 在位内膜样本取自增殖中期(EE-MP n=23;CE-MP n=17)或分泌中期(EE-MS n=17;CE-MS n=9)。
主要发现
- 在位内膜DDR基因表达和γ-H2AFX免疫定位强度在病例组显著高于对照(P<0.05),增殖中期和分泌中期均可见。
- GADD家族蛋白(GADD45A和GADD45G)在病例组在位内膜中丰度存在差异。
- 增殖中期病例组DDR升高与细胞增殖增加相关;DNA修复基因编码的差异表达转录本多数上调。
- 分泌中期病例组多数DNA修复基因差异表达转录本下调,与增殖中期模式相反。
- GSE51981数据集分析也显示病例组与对照组间DDR和DNA修复基因表达有显著改变(P<0.05)。
关键数值与推荐
- 增殖中期病例组与对照组残余DNA损伤细胞百分比相当(P>0.05)。
临床怎么用
- 提示子宫内膜异位症患者在位内膜存在DDR调控异常,可能反映其遭遇更强或更持久的DNA损伤刺激。
- DDR和DNA修复基因表达改变可能为探索子宫内膜异位症起源或进展机制提供线索。
局限性
- 研究样本量有限。
- 未揭示在位内膜DDR失调的原因。
- RNA测序数据受小样本量限制,辅以公共数据集分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the DNA damage response (DDR) dysregulated in the eutopic endometrium of women with endometriosis? SUMMARY ANSWER: Endometrial expression of genes involved in DDR is modulated in women with endometriosis, compared to those without the disease. WHAT IS KNOWN ALREADY: Ectopic endometriotic lesions are reported to harbour somatic mutations, thereby hinting at dysregulation of DDR and DNA repair pathways. However, it remains inconclusive whether the eutopic endometrium also manifests dysregulated DDR in endometriosis. STUDY DESIGN, SIZE, DURATION: For this case-control study conducted between 2015 and 2019, eutopic endometrial (E) samples (EE- from women with endometriosis, CE- from women without endometriosis) were collected in either mid-proliferative (EE-MP, n = 23; CE-MP, n = 17) or mid-secretory (EE-MS, n = 17; CE-MS, n = 9) phases of the menstrual cycle. This study compares: (i) DNA damage marker localization, (ii) expression of DDR genes and (iii) expression of DNA repair genes in eutopic endometrial samples from women with and without endometriosis. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included (i) 40 women (aged 31.9 ± 0.81 years) with endometriosis and (ii) 26 control women (aged 31.4 ± 1.02 years) without endometriosis. Eutopic endometrial samples from the two groups were divided into different parts for histological analysis, immunohistochemistry, RNA extraction, protein extraction and comet assays. Eighty-four genes of relevance in the DNA damage signalling pathway were evaluated for their expression in eutopic endometrial samples, using RT2 Profiler PCR arrays. Validations of the expression of two GADD (Growth Arrest DNA Damage Inducible) proteins - GADD45A and GADD45G were carried out by immunoblotting. DNA damage was assessed by immunohistochemical localization of γ-H2AFX (a phosphorylated variant of histone H2AX) and 8-OHdG (8-hydroxy-2'-deoxyguanosine). RNA sequencing data from mid-proliferative (EE-MP, n = 4; CE-MP, n = 3) and mid-secretory phase (EE-MS and CE-MS, n = 4 each) endometrial samples were scanned to compare the expression status of all the genes implicated in human DNA repair. PCNA (Proliferating Cell Nuclear Antigen) expression was determined to assess endometrial proliferation. Residual DNA damage in primary endometrial cells was checked by comet assays. Public datasets were also scanned for the expression of DDR and DNA repair genes as our RNASeq data were limited by small sample size. All the comparisons were made between phase-matched endometrial samples from women with and without endometriosis. MAIN RESULTS AND THE ROLE OF CHANCE: Endometrial expression of DDR genes and intensity of immunolocalized γ-H2AFX were significantly (P < 0.05) higher in EE, compared to CE samples. DDR proteins, especially those belonging to the GADD family, were found to be differentially abundant in EE, as compared to CE. These patterns were evident in both mid-proliferative and mid-secretory phases. Intriguingly, higher DDR was associated with increased cell proliferation in EE-MP, compared to CE-MP. Furthermore, among the differentially expressed transcripts (DETs) encoded by DNA repair genes, the majority showed up-regulation in EE-MP, compared to CE-MP. Interestingly, CE-MP and EE-MP had a comparable percentage (P > 0.05) of cells with residual DNA damage. However, unlike the mid-proliferative phase data, many DETs encoded by DNA repair genes were down-regulated in EE-MS, compared to CE-MS. An analysis of the phase-matched control and endometriosis samples included in the GSE51981 dataset available in the Gene Expression Omnibus database also revealed significant (P < 0.05) alterations in the expression of DDR and DNA repair genes in EE, compared to CE. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The study was conducted on a limited number of endometrial samples. Also, the study does not reveal the causes underlying dysregulated DDR in the eutopic endometrium of women with endometriosis. WIDER IMPLICATIONS OF THE FINDINGS: Alterations in the expression of DDR and DNA repair genes indirectly suggest that eutopic endometrium, as compared to its healthy counterpart, encounters DNA damage-inducing stimuli, either of higher strength or for longer duration in endometriosis. It will be worthwhile to identify the nature of such stimuli and also explore the role of higher genomic insults and dysregulated DDR/DNA repair in the origin and/or progression of endometriosis. STUDY FUNDING/COMPETING INTEREST(S): The study was supported by the Department of Biotechnology and Indian Council of Medical Research, Government of India. No conflict of interest is declared.
引用
- Bane K, Desouza J, Shetty D, et al. Endometrial DNA damage response is modulated in endometriosis. Hum Reprod. 2021. PMID: 33246341. doi:10.1093/humrep/deaa255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。